Triazolopyrazine

The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceu...

Full description

Saved in:
Bibliographic Details
Main Authors SMETHURST, CHRISTIAN, ENGELHARDT, HARALD, GIANNI, DAVIDE
Format Patent
LanguageChinese
English
Published 16.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
AbstractList The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
Author GIANNI, DAVIDE
SMETHURST, CHRISTIAN
ENGELHARDT, HARALD
Author_xml – fullname: SMETHURST, CHRISTIAN
– fullname: ENGELHARDT, HARALD
– fullname: GIANNI, DAVIDE
BookMark eNrjYmDJy89L5WQQCCnKTKzKz8kvqCxKrMrMS-VhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGhibGJhbGFo7GxKgBAKBFIbE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW201434838A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW201434838A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:53:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW201434838A3
Notes Application Number: TW20132141767
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140916&DB=EPODOC&CC=TW&NR=201434838A
ParticipantIDs epo_espacenet_TW201434838A
PublicationCentury 2000
PublicationDate 20140916
PublicationDateYYYYMMDD 2014-09-16
PublicationDate_xml – month: 09
  year: 2014
  text: 20140916
  day: 16
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies BOEHRINGER INGELHEIM INTERNATIONAL GMBH
RelatedCompanies_xml – name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Score 3.06484
Snippet The present invention encompasses compounds of general formula (I) wherein the groups R1 to R3 have the meanings given in the claims and in the specification....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Triazolopyrazine
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140916&DB=EPODOC&locale=&CC=TW&NR=201434838A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5MSzJJNTLWNQdWbromicnAPJdilqSblmgCbL-mGqdagjfS-vqZeYSaeEWYRjAxZMH2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO8YdHqToZmai5Ota4C_i7-zmrOzbUi4ml8QWM7YxMLYwpGZgRXYjDYH5QbXMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwCIcC0UgUsqwoqi8BnQosyKLq5hjh76AKNjof7Iz4kHOEKYzEGFmD_PlWCQSHJNDHVMBnYOzQ2SDNJSk5MSrZIMjOySDIyBlbuqcnGkgxSuM2RwicpzcAF4oCWNxiayTCwlBSVpsoC69CSJDmw5wGrnHVQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU5MSzJJNTLWNQdWbromicnAPJdilqSblmgCbL-mGqdagjfS-vqZeYSaeEWYRjAxZMH2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO8YdHqToZmai5Ota4C_i7-zmrOzbUi4ml8QWM7YxMLYwpGZgRXYxDYH5QbXMCfQrpQC5CrFTZCBLQBoWl6JEANTVYYwA6cz7OY1YQYOX-iEN5AJzXvFIgwCIcC0UgUsqwoqi8BnQosyKLq5hjh76AKNjof7Iz4kHOEKYzEGFmD_PlWCQSHJNDHVMBnYOzQ2SDNJSk5MSrZIMjOySDIyBlbuqcnGkgxSuM2Rwicpz8DpEeLrE-_j6ectzcAFkgAtdTA0k2FgKSkqTZUF1qclSXLggAAAVdV4Qw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Triazolopyrazine&rft.inventor=SMETHURST%2C+CHRISTIAN&rft.inventor=ENGELHARDT%2C+HARALD&rft.inventor=GIANNI%2C+DAVIDE&rft.date=2014-09-16&rft.externalDBID=A&rft.externalDocID=TW201434838A